Stay updated on GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Sign up to get notified when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.

Latest updates to the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.6.3, signaling a minor maintenance update. The study details and overall content remain unchanged.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.2. This indicates a minor metadata update to the study record page rather than substantive content changes.SummaryDifference0.0%

- Check29 days agoChange DetectedRecruitment is now closed, and new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study) have been added to the study page, alongside a formatting update to the Intervention/Treatment heading and the page revision to v3.6.0.SummaryDifference0.4%

- Check36 days agoChange DetectedThe page now shows revision: v3.5.5, replacing v3.5.4. This reflects an updated version of the study record's metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedLakefront Biotherapeutics NV is now listed as sponsor, replacing Galapagos NV. This indicates a shift in the organization responsible for the trial's conduct and governance.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record shows a new revision identifier, updating from v3.5.3 to v3.5.4, indicating a minor update to the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to GLPG2451 and GLPG2222 Combination in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2451 and GLPG2222 Combination in CF Clinical Trial page.